Neurona Therapeutics: Funding, Investors & Team (Sep 2026)
Neurona Therapeutics is a biotechnology company in the pre-clinical stage, founded by four neuroscientists and stem cell pioneers from The University of California, San Francisco. The company is dedicated to creating and developing cell-based therapies for treating challenging neurological diseases. Their primary goal is to create therapeutic formulations of a specific type of nerve cell for direct delivery to damaged areas of the nervous system. Drawing from nearly two decades of research, they believe that certain subgroups of neurons possess the unique ability to mend and restore malfunctioning neural networks. The company's team of skilled scientists, scientific advisors, and board members are working diligently to expedite the development of groundbreaking treatments for patients facing significant medical challenges.
Neurona Therapeutics has raised $289M across 6 funding rounds on record, the most recent an undisclosed round of $14.0M announced in Jun 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neurona Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Neurona Therapeutics Funding Rounds
Neurona Therapeutics raised $41.5M in an undisclosed round announced in Jun 2021.
11 months later, a Grant of $8.0M was announced in May 2022.
1.8 years later, a Series E of $120M was announced in Feb 2024.
7 months later, an undisclosed round of $3.8M was announced in Sep 2024.
7 months later, an undisclosed round of $102M was announced in Apr 2025.
2 months later, an undisclosed round of $14.0M was announced in Jun 2025.
Neurona Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Neurona Therapeutics Funding Compared to Other Biotechnology Startups
Neurona Therapeutics' latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurona Therapeutics in Biotechnology and San Francisco
Companies Similar to Neurona Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Neurona Therapeutics Funding FAQs
What does Neurona Therapeutics do?
Neurona Therapeutics is a biotechnology company in the pre-clinical stage, founded by four neuroscientists and stem cell pioneers from The University of California, San Francisco. The company is dedicated to creating and developing cell-based therapies for treating challenging neurological diseases. Their primary goal is to create therapeutic formulations of a specific type of nerve cell for direct delivery to damaged areas of the nervous system. Drawing from nearly two decades of research, they believe that certain subgroups of neurons possess the unique ability to mend and restore malfunctioning neural networks. The company's team of skilled scientists, scientific advisors, and board members are working diligently to expedite the development of groundbreaking treatments for patients facing significant medical challenges.
How much funding has Neurona Therapeutics raised?
Neurona Therapeutics has raised $289M across 6 rounds on record. The most recent is an undisclosed round of $14.0M announced in Jun 2025.
When did Neurona Therapeutics last raise funding?
Neurona Therapeutics' most recent funding round on record is an undisclosed round of $14.0M, announced in Jun 2025.
Who founded Neurona Therapeutics?
FundedIQ lists Arnold Kriegstein (Founder), Cory R Nicholas (Founder) at Neurona Therapeutics.
Who is the CEO of Neurona Therapeutics?
Cory Nicholas is listed as CEO at Neurona Therapeutics.
Where is Neurona Therapeutics headquartered?
Neurona Therapeutics is based in San Francisco, California, United States.
How many employees does Neurona Therapeutics have?
Neurona Therapeutics is in the 101-250 employee band.
How does Neurona Therapeutics' funding compare to other Biotechnology startups?
Neurona Therapeutics' latest round of $14.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Neurona Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurona Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.